2 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Neuracle Science Co., LTD.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1b/2a, Study Evaluating the Safety, PK/PD and Efficacy of NS101 in Healthy Volunteers and SSNHL Patients NS101, Placebo - Seneorineural Deafness, Sudden Sensorineural Hearing Loss | Phase 1 / Phase 2 | Completed | Neuracle Science Co., LTD. | 113 | 2024-02-15 | 2026-11-02 |
| A FIH Study to Assess the Safety and Tolerability of NS Intravenous NS101 Infusion NS101 IV infusion - Neurodegenerative Diseases | Phase 1 | Completed | Neuracle Science Co., LTD. | 64 | 2021-11-04 | 2022-12-23 |
Hearing Loss, Hidden (1) · Hearing Loss, Sensorineural (1) · Hearing Loss, Sudden (1) · Neurodegenerative Diseases (1)
Canada (1) · South Korea (1)
Joseph Park, M.D. (1) · Richard Larouche, M.D. (1)